Cargando…
A novel interaction between soluble epoxide hydrolase and the AT1 receptor in retinal microvascular damage
Clinical studies have suggested that the renin-angiotensin system (RAS) may be a promising therapeutic target in treating diabetic retinopathy (DR). While AT1 receptor blockade decreased the incidence of DR in the DIRECT trial, it did not reduce the DR progression. Lack of understanding of the molec...
Autores principales: | Wang, Mong-Heng, Ibrahim, Ahmed S., Hsiao, George, Tawfik, Amany, Al-Shabrawey, Mohamed |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7728430/ https://www.ncbi.nlm.nih.gov/pubmed/32360774 http://dx.doi.org/10.1016/j.prostaglandins.2020.106449 |
Ejemplares similares
-
Soluble Epoxide Hydrolase in Atherosclerosis
por: Wang, Yi-Xin Jim, et al.
Publicado: (2010) -
The Brain’s Microvascular Response to High Glycemia and to the Inhibition of Soluble Epoxide Hydrolase Is Sexually Dimorphic
por: Nuthikattu, Saivageethi, et al.
Publicado: (2022) -
Soluble Epoxide Hydrolase and Diabetes Complications
por: Anita, Natasha Z., et al.
Publicado: (2022) -
Effects of Soluble Epoxide Hydrolase Deficiency on Acute Pancreatitis in Mice
por: Bettaieb, Ahmed, et al.
Publicado: (2014) -
Inhibition of Soluble Epoxide Hydrolase for Renal Health
por: Liu, Jun-Yan
Publicado: (2019)